Context Therapeutics CNTX
NASDAQ CNTX
$0.24 +0.01 (+4.35%)
At close: Oct 22, 2026 · 4:00 PM EDT

Context Therapeutics (CNTX) Price to Sales (2022 - 2024)

Updated

Analysis

Context Therapeutics (CNTX) Price to Sales (2022 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Context Therapeutics 22.05 Mn -218.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 59.73
Jun 30, 2024 73.27
Mar 31, 2024 22.93
Dec 31, 2023 15.50
Sep 30, 2023 19.03
Jun 30, 2023 21.85
Mar 31, 2023 9.97
Dec 31, 2022 18.96
Sep 30, 2022 80.66
Jun 30, 2022 1,291.22
Mar 31, 2022 7,517.10
API Access

Context Therapeutics Price to Sales API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-sales&ticker=CNTX&period=max&api_key=YOUR_API_KEY